{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T12:06:19Z","timestamp":1762344379279,"version":"build-2065373602"},"reference-count":38,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pathologyjournal.rcpa.edu.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.pathol.2025.04.007","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:57:33Z","timestamp":1750208253000},"page":"855-861","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["High PHD finger protein 19 \u200bexpression predicts inferior prognosis in diffuse large B-cell lymphoma"],"prefix":"10.1016","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8657-0781","authenticated-orcid":false,"given":"Tian","family":"Xue","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang-Nan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan-Ge","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Yan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Qiu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.pathol.2025.04.007_bib1","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/ajh.26151","article-title":"2021 update on diffuse large B cell lymphoma: a review of current data and potential applications on risk stratification and management","volume":"96","author":"Susanibar-Adaniya","year":"2021","journal-title":"Am J Hematol"},{"issue":"14","key":"10.1016\/j.pathol.2025.04.007_bib2","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1200\/JCO.2007.13.6929","article-title":"Phase II study of rituximab plus three cycles of CHOP and involved-field radiotherapy for patients with limited-stage aggressive B-cell lymphoma: Southwest Oncology Group Study 0014","volume":"26","author":"Persky","year":"2008","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.pathol.2025.04.007_bib3","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1182\/blood-2010-03-276246","article-title":"Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte","volume":"116","author":"Coiffier","year":"2010","journal-title":"Blood"},{"issue":"6769","key":"10.1016\/j.pathol.2025.04.007_bib4","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Staudt","year":"2000","journal-title":"Nature (London)"},{"issue":"5","key":"10.1016\/j.pathol.2025.04.007_bib5","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","article-title":"Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes","volume":"24","author":"Chapuy","year":"2018","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.pathol.2025.04.007_bib6","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ccell.2020.03.015","article-title":"A probabilistic classification tool for genetic subtypes of diffuse large B cell lymphoma with therapeutic implications","volume":"37","author":"Wright","year":"2020","journal-title":"Cancer Cell"},{"issue":"12","key":"10.1016\/j.pathol.2025.04.007_bib7","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1038\/nsmb.2458","article-title":"H3K36me3 key to polycomb-mediated gene silencing in lineage specification","volume":"19","author":"Abed","year":"2012","journal-title":"Nat Struct Mol Biol"},{"issue":"10","key":"10.1016\/j.pathol.2025.04.007_bib8","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/nsmb.2669","article-title":"Transcriptional regulation by Polycomb group proteins","volume":"20","author":"Di Croce","year":"2013","journal-title":"Nat Struct Mol Biol"},{"issue":"8","key":"10.1016\/j.pathol.2025.04.007_bib9","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.tcb.2019.05.004","article-title":"The complexity of PRC2 subcomplexes","volume":"29","author":"van Mierlo","year":"2019","journal-title":"Trends Cell Biol"},{"issue":"13","key":"10.1016\/j.pathol.2025.04.007_bib10","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.3390\/cancers13133155","article-title":"Clinical correlations of polycomb repressive complex 2 in different tumor types","volume":"13","author":"Erokhin","year":"2021","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.pathol.2025.04.007_bib11","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S1470-2045(18)30145-1","article-title":"Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study","volume":"19","author":"Italiano","year":"2018","journal-title":"Lancet Oncol"},{"issue":"13","key":"10.1016\/j.pathol.2025.04.007_bib12","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1158\/1078-0432.CCR-19-3741","article-title":"A LYSA phase Ib study of tazemetostat (EPZ-6438) plus R-CHOP in patients with newly diagnosed diffuse large B-cell lymphoma (DLBCL) with poor prognosis features","volume":"26","author":"Sarkozy","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.pathol.2025.04.007_bib13","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1038\/s41375-021-01494-w","article-title":"Inhibition of the deubiquitinating enzyme USP47 as a novel targeted therapy for hematologic malignancies expressing mutant EZH2","volume":"36","author":"Yang","year":"2022","journal-title":"Leukemia"},{"issue":"7671","key":"10.1016\/j.pathol.2025.04.007_bib14","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/nature23881","article-title":"Polycomb-like proteins link the PRC2 complex to CpG islands","volume":"549","author":"Li","year":"2017","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.pathol.2025.04.007_bib15","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.celrep.2016.08.096","article-title":"A high-density map for navigating the human polycomb complexome","volume":"17","author":"Hauri","year":"2016","journal-title":"Cell Rep"},{"issue":"32","key":"10.1016\/j.pathol.2025.04.007_bib16","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abb2745","article-title":"The polycomb-associated factor PHF19 controls hematopoietic stem cell state and differentiation","volume":"6","author":"Vizan","year":"2020","journal-title":"Sci Adv"},{"issue":"14","key":"10.1016\/j.pathol.2025.04.007_bib17","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1182\/blood.2019000578","article-title":"PHF19 promotes multiple myeloma tumorigenicity through PRC2 activation and broad H3K27me3 domain formation","volume":"134","author":"Ren","year":"2019","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.pathol.2025.04.007_bib18","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1186\/s12885-021-08227-3","article-title":"LINC_00355 promotes gastric cancer progression by upregulating PHF19 expression through sponging miR-15a-5p","volume":"21","author":"Zhang","year":"2021","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.pathol.2025.04.007_bib19","doi-asserted-by":"crossref","first-page":"6407","DOI":"10.1038\/s41467-021-26600-5","article-title":"Genome-wide profiling in colorectal cancer identifies PHF19 and TBC1D16 as oncogenic super enhancers","volume":"12","author":"Li","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.pathol.2025.04.007_bib20","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3389\/fphar.2020.00150","article-title":"PHD finger protein 19 enhances the resistance of ovarian cancer cells to compound fuling granule by protecting cell growth, invasion, migration, and stemness","volume":"11","author":"Ruan","year":"2020","journal-title":"Front Pharmacol"},{"issue":"8","key":"10.1016\/j.pathol.2025.04.007_bib21","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.4161\/cc.20095","article-title":"PHF19 and Akt control the switch between proliferative and invasive states in melanoma","volume":"11","author":"Ghislin","year":"2012","journal-title":"Cell Cycle"},{"key":"10.1016\/j.pathol.2025.04.007_bib22","article-title":"Comprehensive pan-cancer genomic analysis reveals PHF19 as a carcinogenic indicator related to immune infiltration and prognosis of hepatocellular carcinoma","volume":"12","author":"Zhu","year":"2021","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.pathol.2025.04.007_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102972","article-title":"Single-cell transcriptome analysis of diffuse large B cells in cerebrospinal fluid of central nervous system lymphoma","volume":"24","author":"Ruan","year":"2021","journal-title":"iScience"},{"issue":"7","key":"10.1016\/j.pathol.2025.04.007_bib24","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"issue":"14","key":"10.1016\/j.pathol.2025.04.007_bib25","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","article-title":"The International Non-Hodgkin\u2019s Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.pathol.2025.04.007_bib26","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2025.04.007_bib27","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/978-1-4939-3204-7_3","article-title":"Tissue microarrays","volume":"1381","author":"Dancau","year":"2016","journal-title":"Methods Mol Biol"},{"issue":"5","key":"10.1016\/j.pathol.2025.04.007_bib28","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1210\/jc.2002-021353","article-title":"Sex steroid hormone receptors in human thymoma","volume":"88","author":"Ishibashi","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.pathol.2025.04.007_bib29","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.molcel.2019.12.019","article-title":"A dimeric structural scaffold for PRC2-PCL targeting to CpG island chromatin","volume":"77","author":"Chen","year":"2020","journal-title":"Mol Cell"},{"issue":"1","key":"10.1016\/j.pathol.2025.04.007_bib30","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1186\/s13046-021-02185-1","article-title":"Insights into high-risk multiple myeloma from an analysis of the role of PHF19 in cancer","volume":"40","author":"Ghamlouch","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.pathol.2025.04.007_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.655201","article-title":"Polycomb factor PHF19 controls cell growth and differentiation toward erythroid pathway in chronic myeloid leukemia cells","volume":"9","author":"Garc\u00eda-Montolio","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.pathol.2025.04.007_bib32","article-title":"High PHD finger protein 19 (PHF19) expression predicts poor prognosis in colorectal cancer: a retrospective study","volume":"9","author":"Li","year":"2021","journal-title":"PeerJ"},{"issue":"6","key":"10.1016\/j.pathol.2025.04.007_bib33","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1080\/00365521.2020.1766555","article-title":"Downregulation of PHF19 inhibits cell growth and migration in gastric cancer","volume":"55","author":"Wang","year":"2020","journal-title":"Scand J Gastroenterol"},{"issue":"11","key":"10.1016\/j.pathol.2025.04.007_bib34","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/s41419-018-1082-z","article-title":"PHF19 promotes the proliferation, migration, and chemosensitivity of glioblastoma to doxorubicin through modulation of the SIAH1\/\u03b2-catenin axis","volume":"9","author":"Deng","year":"2018","journal-title":"Cell Dath Dis"},{"issue":"1","key":"10.1016\/j.pathol.2025.04.007_bib35","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3892\/or.2015.3957","article-title":"MicroRNA-195-5p acts as an anti-oncogene by targeting PHF19 in hepatocellular carcinoma","volume":"34","author":"Xu","year":"2015","journal-title":"Oncol Rep"},{"key":"10.1016\/j.pathol.2025.04.007_bib36","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.51373","article-title":"PHF19 mediated regulation of proliferation and invasiveness in prostate cancer cells","volume":"9","author":"Jain","year":"2020","journal-title":"eLife"},{"issue":"7","key":"10.1016\/j.pathol.2025.04.007_bib37","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1158\/1541-7786.MCR-19-0852","article-title":"Polycomb-like protein 3 induces proliferation and drug resistance in multiple myeloma and is regulated by miRNA-15a","volume":"18","author":"Yu","year":"2020","journal-title":"Mol Cancer Res"},{"issue":"5","key":"10.1016\/j.pathol.2025.04.007_bib38","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ccr.2013.04.011","article-title":"EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation","volume":"23","author":"Beguelin","year":"2013","journal-title":"Cancer Cell"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302525001837?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302525001837?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T12:01:30Z","timestamp":1762344090000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302525001837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0031302525001837"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2025.04.007","relation":{},"ISSN":["0031-3025"],"issn-type":[{"type":"print","value":"0031-3025"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High PHD finger protein 19 \u200bexpression predicts inferior prognosis in diffuse large B-cell lymphoma","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2025.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}